Press Releases

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant. Tinlarebant is an investigational, once-daily oral therapy for the treatment of Stargardt disease type 1 (STGD1), a rare, inherited retinal disease caused by mutations in the ABCA4 gene that leads to progressive and irreversible vision loss. STGD1 affects an estimated 53

Crews focus on remaining outages as weather clears across northern Illinois ComEd crews continue restoring power to customers impacted by multiple rounds of severe storms that moved through northern Illinois beginning Wednesday afternoon. With the most volatile weather now past the region, crews are focused on completing repairs and restoring service to remaining pockets of customers affected by storm damage. Multiple bands of severe weather brought intense rain, frequent lightning and high wind gusts, causing significant damage to ComEd's power infrastructure and resulting in widespread outages across the service territory. At least two tornadoes were confirmed on Thursday, including o

New vertical extends ROMA's sustainable-finance mandate into energy-efficient, behind-the-meter-powered digital infrastructure; Company is evaluating a pipeline of distributed, sub-50 MW AI/HPC investment opportunities, subject to diligence, definitive documentation, and board approval. ROMA, HONG KONG, June 12, 2026 (GLOBE NEWSWIRE) -- ROMA Green Finance Limited (NASDAQ:ROMA) ("ROMA" or the "Company") today announced the establishment of a dedicated investment vertical focused on Artificial Intelligence and High-Performance Computing (AI/HPC) infrastructure. The vertical extends the Company's sustainable-finance and ESG advisory mandate into low-carbon, energy-efficient digital infrastru

Hopkins, STANN CREEK, June 12, 2026 (GLOBE NEWSWIRE) -- Hamanasi Adventure & Dive Resort, Belize's premier luxury adventure and dive resort, proudly announces its recognition as the #1 Hotel in Central America and the #15 Best Hotel in the World in the 2026 Tripadvisor Travelers' Choice® Best of the Best Awards. Aerial view of Hamanasi Resort Treehouse rooms nestled in the coastal forest near Hopkins, Belize   The Travelers' Choice Best of the Best title celebrates the highest level of excellence in the travel industry. It is awarded exclusively to properties that receive a high volume of above-and-beyond reviews and opinions from the Tripadvisor community over a 12-month pe

Taoiseach Micheál Martin TD and CEO of IDA Ireland Michael Lohan join OpenText to announce new Cork Centre of Excellence for EMEA Investment marks the largest in Ireland by a Canadian-headquartered technology company, advancing R&D in agentic AI, sovereign cloud and cyber resilience for EMEA clientsDUBLIN, June 12, 2026 /CNW/ -- OpenText™ (NASDAQ/TSX:OTEX), a Waterloo, Ontario, Canada headquartered global leader in data management for enterprise AI, today announced a €105 million investment that will create 400 new jobs across the company's sites in Ireland over the next three years. The commitment, which doubles OpenText's investment in Ireland, will significantly expand the company's agent

Based on results of CAPItello-281 which prospectively defined PTEN-deficient disease and showed TRUQAP combination reduced risk of radiographic disease progression or death by 19% First-in-class AKT inhibitor moves into second tumor type to address an aggressive form of prostate cancer associated with poor prognosis AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone and prednisone has been approved in the US as the first and only targeted treatment for adult patients with PTEN-deficient metastatic androgen pathway modulation-naïve or sensitive (mAPMN/S) prostate cancer, previously referred to as metastatic hormone-sensitive prostate cancer (mHSPC), as detected by a US

BENTON HARBOR, Mich., June 12, 2026 /PRNewswire/ -- Whirlpool Corporation (NYSE: WHR) ("Whirlpool" or the "Company") is releasing early results as of 5:00 p.m., Central European time (11:00 a.m., New York City time), on June 12, 2026 (the "Early Tender Expiration"), of its previously announced (i) tender offer (the "Tender Offer") to purchase for cash any and all of the outstanding 1.250% Notes due 2026 (the "2026 Notes") and 1.100% Notes due 2027 (the "2027 Notes" and together with the 2026 Notes, the "Notes") of Whirlpool Finance Luxembourg S.à r.l., a private limited liability company (société à responsabilité limitée) organized under the laws of the Grand Duchy of Luxembourg (the "Issuer

All ECAT-Approved Trustees Will Remain in Place BlackRock Advisors, LLC ("BlackRock") announced today the final certified voting results of the 2026 Annual Meeting of Shareholders of BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) (the "Fund"). All nine of the Fund's unanimously approved nominees standing for re-election, Cynthia L. Egan, Lorenzo A. Flores, Stayce D. Harris, R. Glenn Hubbard, W. Carl Kester, John M. Perlowski, Robert Fairbairn, J. Phillip Holloman and Arthur P. Steinmetz, will continue to serve on the Board of Trustees (the "Board"). Each nominee received more support than any dissident nominee, reflecting strong shareholder support for the Board's oversight of

$4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrantsSEATTLE, June 12, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced the closing of its previously announced registered direct offering of 1,363,637 shares (the "Shares") of its common stock, par value $0.18 per share ("Common Stock") (or common stock equivalents in lieu thereof), Series A warrants to purchase up to 1,363,637 shares of Common Stock and short-term Series B warrants to pu

ORLANDO, Fla., June 12, 2026 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the "Company" or "Gencor") (NYSE:GENC) announced today net revenue for the quarter ended March 31, 2026 was $33,799,000 compared with $38,204,000 net revenue for the quarter ended March 31, 2025. The decrease in net revenue was primarily due to lower contract equipment revenues recognized over time and associated freight revenue, which resulted from the timing of orders and shipments. As a percentage of net revenue, gross profit margins increased 200 basis points to 31.7% in the quarter ended March 31, 2026, compared to 29.7% in the quarter ended March 31, 2025. Product engineering and development expenses decreased

NEWTOWN, Pa., June 12, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ:TRAW, the Company)), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today announced that the planned test of tivoxavir marboxil (TXM) in a Phase 2a human influenza challenge study has been deferred due to a negative review of the program by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA). "Tivoxavir marboxil demonstrated potent efficacy in three animal models of highly pathogenic avian influenza and a pharmacokinetic profile consistent with its use for bird flu treatment and prevention," said C. David Pauza, PhD Chief Science

NORTH LIBERTY, Iowa, June 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Heartland Express, Inc. (NASDAQ:HTLD) announced today the declaration of a regular quarterly cash dividend. The $0.02 per share dividend will be paid on July 6, 2026, to shareholders of record at the close of business on June 23, 2026. We currently estimate that a total of $1.6 million will be paid on the Company's approximate seventy-eight million shares of common stock. This is the Company's ninety-second consecutive quarterly cash dividend. With the payment of this dividend, the Company will have paid a total of $564.5 million in cash dividends, including four special dividends since the dividend program wa

BlackRock has one of the most comprehensive investment platforms in the industry, providing investors with choice to meet their individual needs. Investors continue to turn to BlackRock to unlock the full potential of their portfolios, as evidenced by nearly $2 trillion of net inflows in the past five years globally.1 As we evolve our global investment platform, we also continually assess how our funds are meeting investors' investment objectives and the needs of our clients. As a result of that exercise, and reflecting evolving investor demand, BlackRock is announcing the upcoming liquidation of 19 U.S.-domiciled mutual funds and ETFs. In the U.S., BlackRock offers nearly 700 mutual fund

TechCreate Group Ltd. (NYSE:TCGL) ("TechCreate" or the "Company"), a technology consultancy and advanced software solutions provider specializing in payment solutions, cybersecurity, and digital services, provided a statement in light of NYSE American LLC's ("NYSE American") announcement that it intends to commence proceedings to delist TechCreate's Class A ordinary shares from the NYSE American stock exchange and, in the interim, to continue to suspend the Company's shares from trading.Following the NYSE Regulation's June 11, 2026 notice to the Company regarding the intended delisting, the Company has and will continue to consult with its legal counsel and other advisors to evaluate its opt

DOWNERS GROVE, Ill., June 12, 2026 /PRNewswire/ -- Federal Signal Corporation (NYSE: FSS) (the "Company"), a leader in environmental and safety solutions, today provided an update on its manufacturing facility in Streator, Illinois following a tornado that impacted the area on June 11, 2026. Initial assessments indicate that the facility sustained no structural damage and all employees are safe, with no reported injuries. The Company continues to evaluate conditions, but operations at the facility are ongoing with no material disruption to production."The safety of our employees and the broader Streator community is our current priority," said Jennifer L. Sherman, President and Chief Executi

Lotus Tech is advancing the strategic acquisition of Lotus UK targeted to close in 2026, to unify brand positioning and improve operational efficiency.Comprehensive pre-acquisition and integration planning is in progress to unlock full synergies and support the execution of the Company's Focus 2030 long-term strategy.The Company temporarily suspends the release of financial results for the first and third quarters in 2026 to prioritize acquisition- related compliance work. NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (NASDAQ:LOT) ("Lotus Tech" or the "Company"), a leading global intelligent and luxury mobility provider, today provided an update on recent developments

CALGARY, Alberta, June 12, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that the Company has elected to voluntarily delist its common shares from the TSX Venture Exchange ("TSXV"). The Company will provide additional information on timing for the completion of the delisting of its common shares in a separate press release. This decision was taken following a comprehensive evaluation, the Company determined that maintaining a dual listing on the TSXV does not justify the asso

Nutrien Ltd. (TSX and NYSE:NTR) has received notice of an unsolicited "mini-tender" offer made by Ocehan LLC ("Ocehan") to purchase up to 100,000 Nutrien common shares, or approximately 0.02% of Nutrien's outstanding shares, at a price of C$70.20 per share. The offering price represents a discount of 24.91% and 26.13%, respectively, to the closing prices of Nutrien shares on the Toronto Stock Exchange and New York Stock Exchange on May 8, 2026, the last trading day before the mini-tender offer was commenced. Nutrien does not endorse Ocehan's unsolicited offer, has no association with Ocehan or its offer, and does not recommend or endorse this unsolicited mini-tender offer. Shareholders ar

BEIJING, June 12, 2026 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE:TAL), a smart learning solutions provider in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended February 28, 2026 (the "Annual Report") with the Securities and Exchange Commission (the "SEC") on June 12, 2026, U.S. Eastern Time. The Annual Report can be accessed and downloaded on the Company's website at https://ir.tal.com/, as well as on the SEC's website at https://www.sec.gov.Shareholders and ADS holders of the Company may request a hard copy of the Annual Report free of charge by emailing the Company at ir@tal.com or by writing to the following address:TAL

NEW YORK, June 12, 2026 /PRNewswire/ -- Bluerock Homes Trust, Inc. (NYSE:BHM) (the "Company") today announced that its Board of Directors has authorized and the Company has declared quarterly cash dividends on the Company's Class A common stock (the "Class A Common Stock") and the Company's Class C common stock (the "Class C Common Stock") for the second quarter of 2026, in each case in the amount of $0.125 per share (collectively, the "Common Dividends"). The Common Dividends will be payable in cash on Thursday, July 2, 2026 to Class A Common stockholders and Class C Common stockholders of record (respectively) as of Thursday,